Minoxidil grows hair primarily by opening potassium channels in the cells of hair follicles, which shifts resting follicles into an active growth phase. Originally developed as a blood pressure medication in the 1970s, its hair-growing side effect led to the topical formulations used today. But the full picture of how it works involves several overlapping mechanisms, from increased blood flow to growth factor signaling.
Potassium Channels and the Follicle
At the cellular level, minoxidil’s active form (minoxidil sulfate, converted by enzymes in your scalp) opens potassium channels on cells in the dermal papilla, the cluster of cells at the base of each hair follicle that controls growth. When these channels open, potassium ions flow out of the cell, changing its electrical charge. This shift triggers a cascade of signals that stimulate the follicle to produce hair. Several structurally different drugs that also open potassium channels have been shown to promote hair growth in lab studies, which is strong evidence that this mechanism is central to the effect.
Research has identified a specific receptor on dermal papilla cells that minoxidil interacts with. These cells also carry receptors for adenosine, a signaling molecule. Minoxidil appears to boost adenosine production, which then activates its own set of receptors on the same cells. Blocking adenosine receptors in lab experiments also blocks minoxidil’s effects, suggesting adenosine acts as a key middleman in the process.
Pushing Follicles Into Growth Mode
Every hair follicle cycles through three phases: active growth (anagen), a brief transition, and a resting phase (telogen) where the hair eventually falls out. In pattern hair loss, follicles spend progressively more time resting and less time growing. Each growth cycle also produces a thinner, shorter hair than the last.
Minoxidil disrupts this decline in two ways. It shortens the resting phase, pushing dormant follicles back into active growth sooner than they otherwise would. It also appears to extend the growth phase itself, giving each hair more time to develop. On top of that, minoxidil increases the physical size of hair follicles, which means the hairs they produce are thicker. This combination of more follicles actively growing, growing for longer, and producing thicker strands is what creates visible improvement.
Blood Flow and Growth Factors
Minoxidil is a vasodilator, meaning it widens blood vessels. Applied to the scalp, a 5% solution increases local blood flow roughly threefold within 15 minutes, an effect that lasts about an hour. More blood flow means more oxygen and nutrients reaching the follicle, which supports the energy-intensive process of hair production.
Minoxidil also ramps up production of vascular endothelial growth factor (VEGF), a protein that stimulates the formation of new blood vessels. In one study, patients taking oral minoxidil had VEGF levels of about 218 pg/ml after treatment compared to 143 pg/ml in the control group. New and expanded blood vessels around the follicle create a richer supply network, reinforcing the growth signal over time.
Why Shedding Happens First
Many people experience increased hair loss during the first few weeks of minoxidil use, sometimes called “dread shed.” This is a direct consequence of the drug’s mechanism. By shortening the resting phase, minoxidil forces follicles that were sitting dormant to eject their old hair and start building a new one. Those hairs would have fallen out eventually on their own over the coming weeks or months. Minoxidil just accelerates the timeline.
This shedding typically starts 2 to 4 weeks after beginning treatment and lasts 3 to 6 weeks. It can be alarming, but it’s actually a sign the drug is working. The hairs that replace them enter a full growth cycle and tend to be thicker than the ones they replaced.
How Long Results Take
Because hair growth is slow, minoxidil requires patience. During months one and two, the main visible change is the shedding described above. By months three to four, most people notice reduced shedding, fine new hairs appearing, and a generally healthier-feeling scalp. Improvement continues gradually from there. Most people reach their maximum response around the 12-month mark. If you stop using minoxidil, the follicles it reactivated will eventually return to their previous resting state, and any regained hair will be lost over several months.
5% vs. 2% Concentration
Topical minoxidil comes in 2% and 5% formulations. In a randomized clinical trial comparing the two in men with pattern hair loss, the 5% solution produced 45% more hair regrowth than the 2% solution after 48 weeks. The higher concentration also kicked in faster, with measurable differences in hair count appearing earlier in the treatment timeline. Both concentrations outperformed placebo, but the 5% solution was clearly superior across every measure: hair count, patient-rated scalp coverage, and investigator-rated coverage.
Topical vs. Oral Minoxidil
Low-dose oral minoxidil has gained traction as an alternative for people who find topical application inconvenient or who experience scalp irritation from the liquid or foam. Oral dosing for men with pattern hair loss typically starts at 1 to 2.5 mg per day, while women usually start at 0.5 to 1 mg per day. The maximum is generally 5 mg daily. Doctors often increase the dose gradually over several months based on response.
Because oral minoxidil enters the bloodstream directly rather than being absorbed through the scalp, it’s more likely to cause systemic effects. The most common is hypertrichosis, or unwanted hair growth on the face, arms, or other body areas, reported in roughly 15% of patients. Cardiovascular effects like a mildly elevated heart rate occur in fewer than 5% of cases. These side effects are dose-dependent and generally resolve if the dose is lowered or the medication is stopped.
Why It Works for Some and Not Others
Minoxidil must be converted into its active form, minoxidil sulfate, by an enzyme called sulfotransferase in the scalp. People vary in how much of this enzyme they produce. Those with higher enzyme activity convert more of the applied minoxidil into its active form and tend to see better results. This enzyme variation is a major reason why minoxidil produces dramatic regrowth in some people and minimal change in others, even at the same concentration. There’s no widely available test for sulfotransferase activity yet, so response is still largely a matter of trying the treatment and observing results over several months.